NO20052308L - Nye benzoksazociner og deres terapeutiske anvendelse. - Google Patents

Nye benzoksazociner og deres terapeutiske anvendelse.

Info

Publication number
NO20052308L
NO20052308L NO20052308A NO20052308A NO20052308L NO 20052308 L NO20052308 L NO 20052308L NO 20052308 A NO20052308 A NO 20052308A NO 20052308 A NO20052308 A NO 20052308A NO 20052308 L NO20052308 L NO 20052308L
Authority
NO
Norway
Prior art keywords
benzoxazocines
novel
disorders
therapeutic use
emesis
Prior art date
Application number
NO20052308A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052308D0 (no
Inventor
Andrew Douglas Baxter
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229743A external-priority patent/GB0229743D0/en
Priority claimed from GB0316914A external-priority patent/GB0316914D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NO20052308D0 publication Critical patent/NO20052308D0/no
Publication of NO20052308L publication Critical patent/NO20052308L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/22—Eight-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Noodles (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
NO20052308A 2002-12-20 2005-05-11 Nye benzoksazociner og deres terapeutiske anvendelse. NO20052308L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0229743A GB0229743D0 (en) 2002-12-20 2002-12-20 Novel benzoxazocines
GB0316914A GB0316914D0 (en) 2003-07-18 2003-07-18 Novel benzoxazocines
PCT/GB2003/005708 WO2004056788A1 (fr) 2002-12-20 2003-12-22 Benzoxazocines et utilisation de ceux-ci comme inhibiteurs de la recapture des mono-amines

Publications (2)

Publication Number Publication Date
NO20052308D0 NO20052308D0 (no) 2005-05-11
NO20052308L true NO20052308L (no) 2005-09-05

Family

ID=32683980

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052308A NO20052308L (no) 2002-12-20 2005-05-11 Nye benzoksazociner og deres terapeutiske anvendelse.

Country Status (14)

Country Link
EP (2) EP1572672B1 (fr)
JP (1) JP2006522012A (fr)
AT (1) ATE404543T1 (fr)
AU (1) AU2003295171B2 (fr)
BR (1) BR0317467A (fr)
CA (1) CA2503172A1 (fr)
DE (1) DE60322947D1 (fr)
ES (1) ES2311749T3 (fr)
MX (1) MXPA05006653A (fr)
NO (1) NO20052308L (fr)
NZ (1) NZ539488A (fr)
PL (1) PL377664A1 (fr)
PT (1) PT1572672E (fr)
WO (1) WO2004056788A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529611C (fr) 2002-12-20 2009-12-15 Pfizer Products Inc. Derives de pyrimidine destines au traitement de la croissance cellulaire anormale
CA2558741A1 (fr) * 2004-04-21 2005-11-03 Sosei R&D Ltd. Benzoxazocines et utilisation therapeutique de celles-ci comme inhibiteurs du recaptage de la monoamine
GB2413322A (en) * 2004-04-21 2005-10-26 Arakis Ltd Nefopam analogues
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB0504960D0 (en) * 2005-03-10 2005-04-20 Arakis Ltd Benzoxazocines
GB0506835D0 (en) * 2005-04-04 2005-05-11 Arakis Ltd Therapeutic use of nefopam
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
GB0609793D0 (en) * 2006-05-17 2006-06-28 Arakis Ltd Racemisation and recycling process
JP5194607B2 (ja) * 2006-07-26 2013-05-08 大正製薬株式会社 ソーシャルインターラクションの低下予防・改善剤
CA2782472C (fr) 2009-12-15 2019-04-16 The Hospital For Sick Children Procede de traitement de cicatrices et de troubles a mediation par la catenine a l'aide de composes du nefopam

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) * 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3978085A (en) * 1975-03-07 1976-08-31 Riker Laboratories, Inc. Process for benz[f]-2,5-oxazocines
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
GB1586578A (en) * 1977-08-05 1981-03-18 Riker Laboratories Inc Process for the preparation of 2-(n-(2-hydroxyyethyl)-n-lower alkylaminomethyl) benzhydrols
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use

Also Published As

Publication number Publication date
NZ539488A (en) 2008-03-28
BR0317467A (pt) 2005-11-16
AU2003295171A1 (en) 2004-07-14
EP1950206A1 (fr) 2008-07-30
NO20052308D0 (no) 2005-05-11
EP1572672B1 (fr) 2008-08-13
HK1075896A1 (en) 2005-12-30
AU2003295171B2 (en) 2007-09-06
WO2004056788A1 (fr) 2004-07-08
MXPA05006653A (es) 2005-09-30
ES2311749T3 (es) 2009-02-16
PT1572672E (pt) 2008-10-02
DE60322947D1 (de) 2008-09-25
EP1572672A1 (fr) 2005-09-14
JP2006522012A (ja) 2006-09-28
CA2503172A1 (fr) 2004-07-08
ATE404543T1 (de) 2008-08-15
PL377664A1 (pl) 2006-02-06

Similar Documents

Publication Publication Date Title
NO20052308L (no) Nye benzoksazociner og deres terapeutiske anvendelse.
EA200601269A1 (ru) Лекарственное средство, содержащее производные фенилпиперазина
NO20043098L (no) Alfa-(N-sulfonamido) acetamidderivater som beta-amyloidinhibitorer
CY1109832T1 (el) Επεξεργασια τρυγικης φορμοτερολης και πολυμορφο
DK0863875T3 (da) Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser
NZ527470A (en) Acylated indanyl amines and their use as pharmaceuticals
ATE366724T1 (de) Kondensierte heterocyclische derivate
CY1108808T1 (el) Ενωσεις μοτιλιδης
AR041298A1 (es) Derivados de pirrolidona como inhibidores de maob
SE0401970D0 (sv) Novel compounds
WO2002085896A8 (fr) Derives azaheterocyclylmethyle antidepresseurs de 2,3-dihydro-1,4-benzodioxane
EP1400513A4 (fr) Compose diamine cyclique asymetrique
PA8540101A1 (es) Metodo para el tratamiento de enfermedades o condiciones por desmielinizacion
DE60201590D1 (de) Antidepressiv wirksame azaheterocyclymethyl-derivative von oxaheterocycyl-anellierten (1,4)-benzodioxanen
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
PT1392700E (pt) Derivados aza-heterociclilmetilo antidepressivos de 7,8-di-hidro-1,6,9-troxa-3-aza-ciclopenta(a)naftaleno
DK1401839T5 (da) Antidepressive (SSSRI) azaheterocyclylmethylderivater af 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalen
NO20055206L (no) 4-(2-fenyloksyfenyl)-piperidin eller -1,2,3,6-tetrahydropyridinderivater som serotonin-reopptaksinhibitorer
MXPA05010678A (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina.
DK0614888T3 (da) Tetrahydrocyclopentab indol-methanaminer og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler.
DK0703232T3 (da) 2,3-Dihydro-1H-isoindolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som hæmmere af serotoningenoptagelsen
PE20060458A1 (es) Tetrahidroisoquinolinas sustituidas en calidad de inhibidores de mpm y procedimiento para su preparacion
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
ES2194033T3 (es) Amino-alquiloximas, un procedimiento para su preparacion, su uso como medicamentos y compuestos intermedios.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application